Home
>
National Drug Code (NDC)
>
REFISSA
REFISSA - 62032-411-20 - (TRETINOIN)
Drug Information of REFISSA
| Product NDC: | 62032-411 |
| Proprietary Name: | REFISSA |
| Non Proprietary Name: | TRETINOIN |
| Active Ingredient(s): | .5 mg/g & nbsp; TRETINOIN |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of REFISSA
| Product NDC: | 62032-411 |
| Labeler Name: | Obagi Medical Products, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076498 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100222 |
Package Information of REFISSA
| Package NDC: | 62032-411-20 |
| Package Description: | 20 g in 1 TUBE (62032-411-20) |
NDC Information of REFISSA
| NDC Code | 62032-411-20 |
| Proprietary Name | REFISSA |
| Package Description | 20 g in 1 TUBE (62032-411-20) |
| Product NDC | 62032-411 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TRETINOIN |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20100222 |
| Marketing Category Name | ANDA |
| Labeler Name | Obagi Medical Products, Inc. |
| Substance Name | TRETINOIN |
| Strength Number | .5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
